The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and PK results from a phase Ib study of AL3818 (anlotinib) hydrochloride in subjects with ovarian, cervical, and endometrial cancers.
 
Theresa Louise Werner
Research Funding - AbbVie (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Esther Kannapel
No Relationships to Disclose
 
Judy Chen
Employment - Advenchen Laboratories; CVS Caremark; Pharmaca
Leadership - Advenchen Laboratories
Stock and Other Ownership Interests - Advenchen Laboratories; Gilead Sciences
Research Funding - Advenchen Laboratories
Patents, Royalties, Other Intellectual Property - Advenchen Laboratories
Other Relationship - Advenchen Laboratories
 
Melissa Chen
Employment - Advenchen Laboratories
Stock and Other Ownership Interests - Advenchen Laboratories
Consulting or Advisory Role - Advenchen Laboratories
Research Funding - Advenchen Laboratories
Patents, Royalties, Other Intellectual Property - Advenchen Laboratories
 
Adam Louis Cohen
Research Funding - Abbvie; Bristol-Myers Squibb; Merrimack; Novartis; Roche/Genentech